Jason Okazaki

President, CEO & Director at Assembly Biosciences

Mr. Okazaki is Assembly’s Chief Executive Officer and President as well as a member of the Board. Mr. Okazaki joined Assembly in 2020 as its Chief Legal and Business Officer and was promoted to President and Chief Operating Officer. Prior to joining Assembly Bio, he served as Senior Vice President, Legal and Assistant Secretary at Gilead Sciences. During his 14-year career there, he built and led a global legal team supporting operations in the United States, Asia and Latin America, and advised on corporate governance and U.S. Securities and Exchange Commission (SEC) reporting matters. Over this period, he also led the structuring and legal execution efforts for Gilead’s acquisitions, divestitures and strategic collaborations. Prior to Gilead, he was an associate at Skadden, Arps, Slate, Meagher & Flom LLP in the law firm’s mergers and acquisitions and corporate finance practices. Mr. Okazaki earned a BA in Economics from Stanford University and a JD from the UC Hastings College of the Law.

Links


Org chart

Sign up to view 10 direct reports

Get started